MGO One Seven’s Alaunos Therapeutics TCRT Stock Holding History

MGO One Seven’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-95	Closed	-$21K	–	693
2021 Q3	$21K	Hold	95	–	–	﹤0.01%	602
2021 Q2	$37K	Sell	95 -20	-17%	-$9.34K	0.01%	587
2021 Q1	$61K	Buy	+115	New	+$71.6K	0.01%	546

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MGO One Seven's TCRT Position: Q4 2021 in Review

MGO One Seven sold out of Alaunos Therapeutics (TCRT) in Q4 2021, closing a stake of 95 shares — an estimated $21K sold.

MGO One Seven first reported a position in TCRT in Q1 2021 and held it in 3 quarters. The position peaked at $61K in Q1 2021. 165 funds tracked by Wall St. Rank hold TCRT as of Q4 2021.

MGO One Seven reported no remaining Alaunos Therapeutics position as of Q4 2021 after selling out during the quarter.
MGO One Seven sold 95 Alaunos Therapeutics shares in Q4 2021, an estimated $21K.
MGO One Seven first reported a position in Alaunos Therapeutics in Q1 2021 and held it in 3 quarters.
MGO One Seven's Alaunos Therapeutics position peaked at $61K in Q1 2021.
165 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2021.

Based on MGO One Seven's 13F filing for Q4 2021, filed 9 Feb 2022.